Advertisement Press Releases Archive - Page 6 of 231 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

Search

  • 03 Aug 2023
    Continuing the Success Story

    Continuing the Success Story

    By Nat Schaefer

    Gerresheimer, an innovative system and solution provider and global partner for the pharma and biotech industry, is dedicating even more space to small-batch production. It has expanded the capacity of its small-batch production (SBP) area in Wackersdorf by removing a section of the high-bay warehouse and converting it into a manufacturing space. The new Small Batch Production Sampling Area Wackersdorf measures 700m² and will be used to manufacture pre-series parts for assembly systems. The expansion is a further display of Gerresheimer’s far-reaching industrialisation expertise in the manufacture of containment solutions, drug delivery systems and medical devices.

  • 11 Jul 2023
    Gerresheimer Launches Open Innovation Programme for the Development of Home Therapy Solutions

    Gerresheimer Launches Open Innovation Programme for the Development of Home Therapy Solutions

    By Nat Schaefer

    As an innovative system and solution provider, Gerresheimer is the global partner for the pharma and biotech industry. In collaboration with ekipa, a leading incubator for open innovation, Gerresheimer is calling on startups, companies, students, researchers and young professionals to enable or improve patient care at home with (digital) services and solutions. The best solution will be awarded €4,000 in prize money and the winner can work together with Gerresheimer on further development. The call for entries starts now and ends on 27 August 2023.

  • 06 Jul 2023
  • 07 Jun 2023
  • 24 Apr 2023
  • 20 Apr 2023
    Rethinking Pharmaceutical Glass Standards: The Need for Dedicated Testing Strategies

    Rethinking Pharmaceutical Glass Standards: The Need for Dedicated Testing Strategies

    By Nat Schaefer

    The US Pharmacopeia (USP) has proposed a revision to General Chapter <660> Container—Glass, which provides specifications for glass containers used in the pharmaceutical industry. These modifications aim to modernise tests and test methods alongside specifications within the chapter. The underlying goal is to create additional flexibility for packaging and storage requirements. However, many experts in the pharmaceutical industry believe that this is a short-sighted move.

  • 17 Mar 2023
    Join Us at DIA Europe 2023 – 22-24 March in Basel, Switzerland

    Join Us at DIA Europe 2023 – 22-24 March in Basel, Switzerland

    By Nat Schaefer

    For 35 years now, DIA EUROPE is the largest neutral event in the European life science industry – the knowledge hub between science, healthcare, and regulation – and the place to meet trusted colleagues and make new connections with the brightest minds passionate about advancing health priorities.

  • 17 Mar 2023
    Successful FDA Inspection at Gerresheimer Peachtree City, USA

    Successful FDA Inspection at Gerresheimer Peachtree City, USA

    By Nat Schaefer

    The Gerresheimer subsidiary in Peachtree City, USA, was named an approved “Contract Manufacturer for VERO Biotech’s GENOSYL Delivery System (DS), drug substance intermediate” for the disposable cassette of the company’s third generation of the first tankless inhaled nitric oxide delivery system. As part of the product’s approval on the American market, the entire manufacturing strategy was examined by the United States Food and Drug Administration.

  • 02 Mar 2023
  • 02 Mar 2023
«‹45678›»